Table 1 Characteristics of patients following myocardial infarction, Tayside
PrehospitalIn-hospitalPost-hospital
DeadDeadAliveDeadAlive
No%No%No%No%No%
Distance (miles)†
    <3128731.740741.6175333.0**67836.5107531.1**
    3–9134633.230431.0180133.960732.7119434.6
    >8142335.126827.4175633.157230.8118434.3
Sex
    Male202949.144343.9327060.6**101753.3225364.5**
    Female210450.956756.1212839.489046.7123835.6
Age (mean, SD)77.210.978.59.667.512.6**74.610.263.712.1**
Deprivation category†
    1, least deprived1754.4474.83135.91005.42136.1
    283320.917217.498018.432517.665518.8
    3118729.831231.6150828.350227.3100628.8
    442410.712212.356110.521611.73459.9
    548712.211111.264812.222112.042712.2
    6+, most deprived87623.022522.8132024.847826.074224.1
Travel time (mean, SD)17.315.319.314.9**20.415.718.715.4**
Urban-rural code‡
    1160340.538538.6235644.0**81343.5154344.2
    2100325.428929.0141026.352728.288325.3
    3, 6118129.928018.0143126.746725.096427.6
    7, 81674.2444.41633.0623.31012.9
Previous hospitalisation
    Angina44510.812112.069112.829515.539611.3**
    Heart failure84520.527727.4140226.0**82143.158116.6**
    Stroke43310.511111.02715.0**1739.1982.8**
    Hypertension43210.513113.064512.0*23312.241211.8**
    PVD46211.212812.74237.8**23212.21915.5**
    Diabetes56713.714614.571513.232717.238811.1**
Cardiovascular drug use in the previous year‡
    Lipid-lowering drug3257.9979.666712.4*55429.1266076.2**
    Antiplatelets156938.038638.2155628.8**120563.2290783.3**
    β-blockers114827.830229.9168431.253928.3226464.9**
    ACE inhibitors86821.018818.678714.6**76540.1205458.8**
    Diuretics257062.262862.2211039.1**105255.2138839.8**
    α-blockers1984.8565.52574.8**542.81233.5
    Nitrates143834.837437.0162730.1**104754.9243569.8**
    Ca-blockers137033.237036.6169431.451827.2117733.7**
  • Data are numbers and percentages unless otherwise stated.

  • *Comparison of dead and alive patients, p<0.05; **p<0.01. †Excluding missing data. ‡Drug uses during the follow-up for post-hospital cohort.

  • ACE, angiotensin-converting enzyme; PVD, peripheral vascular disease.